Journal Basic Info
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.Major Scope
- Thoracic Oncology
- Gastrointestinal Cancer
- Radiological Techniques and Scans
- Urological Cancers
- Gynecological Cancers
- Melanoma/Skin Cancer
- Adjuvant Therapy
- Carcinomas
Abstract
Citation: Clin Oncol. 2018;3(1):1426.DOI: 10.25107/2474-1663.1426
Metastatic Soft Tissue Sarcomas: A Review of Treatments and New Pharmacotherapies
Mahesh Seetharam, Kantha R Kolla and Sant P Chawla
Division of Hematology/Oncology, Mayo Clinic, USA
*Correspondance to: Mahesh Seetharam
PDF Full Text Review Article | Open Access
Abstract:
Soft Tissue Sarcomas (STS) are a heterogeneous group of rare tumors which arise from mesenchymal cells. The malignant precursor cells may differentiate into several lineages such as muscle, adipose, fibrous, cartilage, nerve or vascular tissue to name a few. There are over 50 different subtypes of soft tissue sarcomas, of which undifferentiated pleomorphic sarcoma, adipocytic sarcoma, leiomyosarcoma, nerve sheath sarcoma being more common. The treatment options for soft tissue sarcoma include surgery, radiation therapy, chemotherapy and targeted therapy. In this article we focus on approved treatments and newer therapeutic approaches for management of soft tissue sarcomas.
Keywords:
Cite the Article:
Seetharam M, Kolla KR, Chawla SP. Metastatic Soft Tissue Sarcomas: A Review of Treatments and New Pharmacotherapies. Clin Oncol. 2018; 3: 1426.
